This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
ABIOMED (ABMD) to Report Q3 Earnings: What's in the Cards?
by Zacks Equity Research
The strong momentum of ABIOMED's (ABMD) Impella product line, both in Europe and Japan, is expected to have continued in the fiscal third quarter as well.
BD (BDX) Gears Up for Q1 Earnings: What's in the Offing?
by Zacks Equity Research
BD's (BDX) first-quarter fiscal 2021 results are likely to reflect strong year-over-year growth in revenues from assays in its Life Sciences segment.
Stryker (SYK) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Stryker's (SYK) fourth-quarter results are likely to reflect strong segmental performances at Medsurg, Orthopaedic and Neurotechnology & Spine.
Celanese (CE) to Report Q4 Earnings: What's in the Offing?
by Zacks Equity Research
Celanese's (CE) Q4 performance is likely to have benefited from productivity actions, investments in high-return organic projects and strategic acquisitions.
Varian (VAR) to Report Q1 Earnings: What's in the Offing?
by Zacks Equity Research
Varian's (VAR) fiscal first-quarter earnings are likely to reflect strength in Halcyon platform.
Freeport (FCX) to Post Q4 Earnings: What's in the Offing?
by Zacks Equity Research
Freeport's (FCX) fourth-quarter results are likely to reflect the benefits of higher copper prices.
PPG Industries (PPG) to Post Q4 Earnings: What's in Store?
by Zacks Equity Research
PPG Industries' (PPG) performance is likely to have benefited from cost-cutting and restructuring actions in Q4.
CE vs. ECL: Which Stock Is the Better Value Option?
by Zacks Equity Research
CE vs. ECL: Which Stock Is the Better Value Option?
WLKP vs. ECL: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
WLKP vs. ECL: Which Stock Is the Better Value Option?
WLKP or ECL: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
WLKP vs. ECL: Which Stock Is the Better Value Option?
WLKP or ECL: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
WLKP vs. ECL: Which Stock Is the Better Value Option?
Ecolab (ECL) Gets EPA Nod for Biofilm Disinfectant Virasept
by Zacks Equity Research
Ecolab's (ECL) Virasept has been developed to combat bacterial growth in hospitals.
Ecolab Introduces Exelerate TUFSOIL for Food Manufacturers
by Zacks Equity Research
Ecolab's (ECL) Exelerate TUFSOIL has been developed to increase production time and enhance cleaning outcomes to curb food safety risks and improve worker safety.
Spate of Upbeat Q3 Earnings Fueling Material ETFs
by Sweta Killa
The string of upbeat results led to smooth trading in materials ETFs over the past month.
WLKP vs. ECL: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
WLKP vs. ECL: Which Stock Is the Better Value Option?
Ecolab (ECL) Earnings and Revenues Surpass Estimates in Q3
by Zacks Equity Research
Although Ecolab's (ECL) third-quarter results reflect weakness in the Global Industrial and Institutional segments, its Global Healthcare and Life Sciences unit shows strength.
Ecolab (ECL) Q3 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Ecolab (ECL) delivered earnings and revenue surprises of 5.50% and 1.49%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
ETFs to Watch on Likely Q3 Earnings Surprise for Materials
by Sweta Killa
With positive earnings estimate revision and earnings surprises in the cards, materials ETFs might continue to see smooth trading in the weeks ahead.
Ecolab (ECL) to Report Q3 Earnings: What's in the Offing?
by Zacks Equity Research
Ecolab's (ECL) Global Industrial segment is likely to have gained from the Water, Food & Beverage and Life Sciences sub-units in Q3.
Ecolab (ECL) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
by Zacks Equity Research
Ecolab (ECL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Ecolab Introduces New Automated Precision Dispensing System
by Zacks Equity Research
Ecolab's (ECL) newly launched Precision Dispensing System for Membranes can drive productivity and boost worker safety.
Ecolab Disinfectant Gets EPA Nod for Use Against SARS-CoV-2
by Zacks Equity Research
Ecolab's (ECL) Peroxide Multi Surface Cleaner and Disinfectant is the first EPA-registered disinfectant proven to be effective at killing the SARS-CoV-2 virus.
Ecolab Launches Sanitizer to Prevent Food-Borne Illness
by Zacks Equity Research
Ecolab's (ECL) Sink & Surface Cleaner Sanitizer is the first EPA-registered product for use against norovirus and SARS-CoV-2.
The Zacks Analyst Blog Highlights: Microsoft, Anthem, Uber, Automatic Data Processing and Ecolab
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Microsoft, Anthem, Uber, Automatic Data Processing and Ecolab
Top Stock Reports for Microsoft, Anthem & Uber
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Microsoft (MSFT), Anthem (ANTM) and Uber Technologies (UBER).